Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$401.46M+17.1%$375.63M+12.1%$355.56M+8.1%$348.66M+6.9%$342.97M+7.5%
$27.89M+27.2%$26.87M+29.5%$24.68M+21.9%$23.18M+16.7%$21.93M+13.6%
$260.98M+20.4%$238.96M+12.8%$223.36M+7.8%$220.61M+7.9%$216.77M+7.1%
$58.07M-2.2%$57.37M-4.2%$58.34M-2.0%$59.52M-0.2%$59.37M+0.6%
$148.11M+4.9%$142.18M+3.0%$147.26M+16.1%$142.93M+12.0%$141.2M+6.9%
36.9%-4.3pp37.9%-3.3pp41.4%+2.9pp41%+1.9pp41.2%-0.3pp
$3.10-1.9%$3.02-3.5%$3.18+9.3%$3.14+6.8%$3.16+3.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is National Health Investors's revenue?
National Health Investors (NHI) generated $401.5M in revenue over the trailing twelve months, up 17.1% year over year.
Is National Health Investors profitable?
National Health Investors reported $148.1M in net income over the trailing twelve months, a 36.9% net margin.
What is National Health Investors's earnings per share?
National Health Investors's diluted EPS over the trailing twelve months is $3.10.
Where does National Health Investors's income statement data come from?
Every line is extracted from National Health Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.